Skip to content

Clinical trials

Phase 2 Mucopolysaccharidosis IV trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mucopolysaccharidosis IV Phase: Phase 2 Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20122
20161
20202
20212
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated4
Completed3
Enrolling by invitation2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
QED Therapeutics, a BridgeBio company4
BioMarin Pharmaceutical3
Pfizer2
BIO-CAT Microbials, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mucopolysaccharidosis IV10
Achondroplasia5
Bone Diseases5
Musculoskeletal Diseases5
Osteochondrodysplasias5
Dwarfism4
Genetic Diseases, Inborn4
Lysosomal Storage Diseases3
Bone Diseases, Developmental1
Growth Disorders1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.